Isotopia and CPDC Successfully Deliver First Doses of n.c.a. Lu-177 to North American Customers
June 9th, 2022 – Israel and Canada June 9th, 2022
We make the complex, simple.
By developing advanced solutions that change lives. Always one step ahead, for you.
Advancing cancer diagnosis and therapy is among the most critical and worthy goals for humanity.
At ISOTOPIA, this goal is our mission.
Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes cutting-edge diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.
We are a multidisciplinary team of experts unified in the mission to expand healthcare providers’ power to diagnose and treat cancer, with greater precision and safety.
June 9th, 2022 – Israel and Canada June 9th, 2022
Take a 360° view of the field of Theranostics and
We look forward to seeing you at the SNMMI 2022